{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T23:07:56Z","timestamp":1794092876887,"version":"4.8.0"},"reference-count":64,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Continuum"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1212\/con.0000000000000807","type":"journal-article","created":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T14:07:10Z","timestamp":1575382030000},"page":"1785-1806","source":"Crossref","is-referenced-by-count":22,"title":["Lambert-Eaton Myasthenic Syndrome, Botulism, and Immune Checkpoint Inhibitor\u2013Related Myasthenia Gravis"],"prefix":"10.1212","volume":"25","author":[{"given":"Amanda C.","family":"Guidon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2016.44"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.13512"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000228225.23349.5d"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-014-8887-2"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/85520"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23944"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1080\/08916934.2016.1214823"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26053"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23508"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24921"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25520"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000130254.27019.14"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri2155"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007600"},{"key":"e_1_3_1_16_2","unstructured":"United States Census Bureau. 2018 national and state population estimates. census.gov\/newsroom\/press-kits\/2018\/pop-estimates-national-state.html. Published December 19 2018. Accessed October 24 2019."},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26052"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002790"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0072-9752(07)01509-6"},{"key":"e_1_3_1_20_2","unstructured":"ClinicalTrials.gov. An efficacy and safety study of ARGX-113 in patients with myasthenia gravis who have generalized muscle weakness (ADAPT). clinicaltrials.gov\/ct2\/show\/NCT03669588. Updated October 2 2019. Accessed October 24 2019."},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181c3f4f1"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2013.08.009"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003794"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1254.065"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25027"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006577"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2011.12.012"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1998.tb11024.x"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23638"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2010.03220.x"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25070"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25700"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26625"},{"key":"e_1_3_1_34_2","unstructured":"US Food & Drug Administration. Drugs@FDA: FDA Approved Drug Products. www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&varApplNo=208078. Accessed October 24 2019."},{"key":"e_1_3_1_35_2","unstructured":"US Food & Drug Administration. Orphan Drug Designations and Approvals. www.accessdata.fda.gov\/scripts\/opdlisting\/oopd\/detailedIndex.cfm?cfgridkey=51590. Accessed October 24 2019."},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02329922"},{"key":"e_1_3_1_37_2","unstructured":"Myasthenia Gravis Foundation of America. Cautionary drugs. myasthenia.org\/What-is-MG\/MG-Management\/Cautionary-Drugs. Accessed October 24 2019."},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2014.09.009"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25009"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2017.09.044"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000000651"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2017.10.035"},{"key":"e_1_3_1_43_2","unstructured":"Centers for Disease Control and Prevention. National botulism surveillance. Centers for Disease Control and Prevention web site. cdc.gov\/botulism\/surveillance.html. Updated June 6 2019. Accessed October 24 2019."},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2017.22.24.30550"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.150941"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix936"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMicm1003352"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2018.00080"},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199912)22:12<1698::AID-MUS12>3.0.CO;2-K"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24737"},{"key":"e_1_3_1_51_2","unstructured":"US Food & Drug Administration. BAT (Botulism Antitoxin Heptavalent (A B C D E F G) - (Equine). www.fda.gov\/BiologicsBloodVaccines\/BloodBloodProducts\/ApprovedProducts\/LicensedProductsBLAs\/FractionatedPlasmaProducts\/ucm345134.htm. Updated December 11 2018. Accessed October 24 2019."},{"key":"e_1_3_1_52_2","unstructured":"Centers for Disease Control and Prevention. Botulism. Information for health professionals. cdc.gov\/botulism\/health-professional.html. Updated October 4 2018. Accessed October 24 2019."},{"key":"e_1_3_1_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.10141"},{"key":"e_1_3_1_54_2","unstructured":"Centers for Disease Control and Prevention. Wound botulism outbreak among persons who use black tar heroin\u2014San Diego County California 2017\u20132018. cdc.gov\/mmwr\/volumes\/67\/wr\/mm675152a3.htm?s_cid=mm675152a3_x). Published January 4 2019. Accessed October 24 2019."},{"key":"e_1_3_1_55_2","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2016.1207826"},{"key":"e_1_3_1_56_2","doi-asserted-by":"publisher","DOI":"10.1177\/1756286418799864"},{"key":"e_1_3_1_57_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.77.6385"},{"key":"e_1_3_1_58_2","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.654"},{"key":"e_1_3_1_59_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1703481"},{"key":"e_1_3_1_60_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004359"},{"key":"e_1_3_1_61_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.3923"},{"key":"e_1_3_1_62_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2018-0359"},{"key":"e_1_3_1_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2018.09.033"},{"key":"e_1_3_1_64_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31629"},{"key":"e_1_3_1_65_2","doi-asserted-by":"publisher","DOI":"10.1159\/000494078"}],"container-title":["Continuum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1212\/CON.0000000000000807","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T14:09:33Z","timestamp":1752156573000},"score":1,"resource":{"primary":{"URL":"https:\/\/continuum.aan.com\/doi\/10.1212\/CON.0000000000000807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["10.1212\/CON.0000000000000807"],"URL":"https:\/\/doi.org\/10.1212\/con.0000000000000807","relation":{},"ISSN":["1080-2371","1538-6899"],"issn-type":[{"value":"1080-2371","type":"print"},{"value":"1538-6899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}